Profile data is unavailable for this security.
About the company
Diaceutics PLC is a United Kingdom-based technology and solutions provider to pharma and biotech companies. It is engaged in research and development activities in the area of drug development science, precision medicine data and platform software. It provides pharma and biotech companies with an end-to-end commercialization solution for precision medicine through data analytics, scientific and advisory services enabled by its platform DXRX - The Diagnostics Network. It has two separate products and service lines: Insight & Engagement Solutions and Scientific & Advisory Services. Insight & Engagement Solutions includes access to the DXRX platform diagnostic testing data repository to utilize licensed data insight products, such as lab segmentation, physician segmentation, testing rate tracker and physician signal. Scientific Advisory Services comprise a range of services developed to help improve patient care by accelerating the development, delivery and uptake of precision medicine.
- Revenue in GBP (TTM)26.10m
- Net income in GBP-2.85m
- Incorporated2005
- Employees184.00
- LocationDiaceutics PLCFirst FloorDataworks - Kingshall BuildingBELFAST BT6 9GWUnited KingdomGBR
- Websitehttps://www.diaceutics.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Synectics PLC | 53.55m | 3.02m | 55.70m | 269.00 | 17.54 | 1.40 | 12.32 | 1.04 | 0.1784 | 0.1784 | 3.17 | 2.24 | 0.9656 | 6.14 | 3.02 | 199,066.90 | 5.44 | -0.236 | 7.21 | -0.334 | 41.21 | 37.25 | 5.63 | -0.2861 | 1.64 | 39.77 | 0.0389 | -- | 25.60 | -7.17 | 238.50 | 7.10 | 7.86 | -8.59 |
| Carillion plc | 4.41bn | -1.07bn | 60.88m | 31.63k | -- | -- | -- | 0.0138 | -2.49 | -2.49 | 9.74 | -1.01 | 1.15 | 60.95 | 3.36 | 139,493.50 | -27.66 | 3.40 | -60.04 | 6.40 | 7.93 | 9.31 | -24.10 | 3.49 | 0.7176 | 0.7203 | 1.73 | 61.00 | 11.24 | 1.14 | -6.48 | -1.60 | 24.24 | 1.77 |
| Anexo Group PLC | 140.30m | 9.46m | 86.13m | 963.00 | 9.19 | 0.5306 | 4.59 | 0.6139 | 0.0795 | 0.0795 | 1.18 | 1.38 | 0.5442 | -- | 0.6012 | 145,686.40 | 3.67 | 8.75 | 5.30 | 12.38 | 75.03 | 78.17 | 6.75 | 14.72 | -- | 1.83 | 0.3044 | 10.23 | 7.96 | 21.45 | -22.36 | 5.80 | -17.82 | 0.00 |
| Knights Group Holdings PLC | 149.96m | 9.85m | 93.54m | 1.43k | 9.81 | 0.934 | 4.29 | 0.6238 | 0.1111 | 0.1111 | 1.69 | 1.17 | 0.6962 | -- | 2.11 | 104,938.40 | 4.57 | 2.23 | 5.35 | 2.68 | -- | -- | 6.57 | 3.44 | -- | 5.51 | 0.4474 | 54.21 | 5.54 | 23.28 | 23.96 | 19.74 | 44.46 | 18.66 |
| Diaceutics PLC | 26.10m | -2.85m | 99.55m | 184.00 | -- | 2.57 | 43.86 | 3.82 | -0.0337 | -0.0337 | 0.3099 | 0.4573 | 0.5701 | -- | 3.11 | 141,820.70 | -6.22 | 0.1106 | -6.90 | 0.1205 | 83.30 | 82.19 | -10.90 | 0.24 | -- | -- | 0.0284 | 0.00 | 21.51 | 17.97 | -341.16 | -- | 34.39 | -- |
| Spectra Systems Corp | 24.95m | 5.23m | 124.60m | -- | 24.21 | 4.67 | 17.97 | 4.99 | 0.105 | 0.105 | 0.4988 | 0.5445 | 0.6364 | 1.94 | 5.35 | -- | 13.31 | 14.84 | 17.09 | 17.39 | 58.23 | 66.19 | 20.91 | 31.57 | 1.13 | 55.19 | 0.1268 | 81.38 | 3.37 | 10.18 | -1.62 | 8.32 | -1.91 | 10.63 |
| Begbies Traynor Group plc | 136.73m | 1.45m | 145.30m | 1.25k | 102.00 | 1.87 | 13.26 | 1.06 | 0.009 | 0.009 | 0.8344 | 0.493 | 0.8829 | -- | 11.12 | 109,382.40 | 0.9377 | 0.7149 | 1.38 | 0.9943 | 43.07 | 43.33 | 1.06 | 0.9461 | -- | 9.85 | 0.1922 | 519.97 | 12.23 | 17.88 | -50.12 | -8.36 | 7.76 | 9.00 |
| Holder | Shares | % Held |
|---|---|---|
| Canaccord Genuity Wealth Ltd.as of 31 Dec 2023 | 7.75m | 9.14% |
| Gresham House Asset Management Ltd. (Investment Management)as of 31 May 2024 | 5.70m | 6.73% |
| Universal-Investment-Gesellschaft mbH (Invt Mgmt)as of 26 Sep 2023 | 4.01m | 4.73% |
| Joh. Berenberg, Gossler & Co. KG (Investment Management)as of 31 Dec 2023 | 3.63m | 4.29% |
| Danske Bank A/S (Investment Management)as of 31 Oct 2024 | 3.33m | 3.93% |
| Herald Investment Management Ltd.as of 31 Dec 2020 | 3.01m | 3.55% |
| BlackRock Investment Management (UK) Ltd.as of 14 Nov 2024 | 2.71m | 3.20% |
| Handelsbanken Fonder ABas of 31 Oct 2024 | 1.52m | 1.79% |
| EdenTree Investment Management Ltd.as of 01 Oct 2024 | 1.43m | 1.69% |
| River Global Investors LLPas of 01 Oct 2024 | 1.40m | 1.65% |
